Loading clinical trials...
Loading clinical trials...
This study aims to investigate the methylomic features of patients with hepatitis B-related acute-on-chronic liver failure and establish and validate a prognostic risk prediction classification model. The findings are of significant importance for guiding clinical practice and improving patient prognosis. Additionally, a methylomics-based classifier model for liver failure will be developed for disease prognosis analysis and clinical assessment, with the potential to enhance the diagnostic efficiency of liver failure.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Qilu Hospital of Shandong University
Jinan, Shandong, China
Start Date
December 31, 2024
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
December 10, 2025
100
ESTIMATED participants
Lead Sponsor
Qilu Hospital of Shandong University
NCT06865859
NCT07388979
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07031219